Parameters of cardiopulmonary exercise testing significantly discriminate between healthy subjects and patients with pulmonary hypertension (PH), also according to the new 2022 definition of pulmonary hypertension (mean pulmonary arterial pressure mPAP > 20 mmHg).

Pulmonary hypertension (PH) is associated with adverse outcomes in chronic kidney disease (CKD) patients.

This article examines technical use of Fitbit during an intervention for pulmonary hypertension (PAH)-patients.

A blood test identifying patients at increased risk of pulmonary hypertension (PH) could streamline the investigative pathway...

Prostacyclin therapy is a mainstay of the management of pulmonary arterial hypertension (PAH).

Pulmonary arterial hypertension (PAH, or PH Group 1), a disease of aberrant pulmonary vascular remodeling, causing progressive right heart failure (RHF) due to elevation of pulmonary vascular resistance (PVR).

In this Community Call, we discussed: 

• Implications of mean pulmonary arterial wedge pressure trajectories in PAH
• Myeloid cell derived IL1β contributes to PH in HFpEF
• Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension

'Bacteria' is part of the Microbes Virtual Symposium series by the iPVD, a global education programme that highlights top-notch research on inflammation and infectious PVD.

Pulmonary hypertension in sickle cell disease (SCD) is a complex phenomenon resulting from multiple overlapping etiologies, including pulmonary vasoconstriction in the setting of chronic hemolytic...